Third, oxidative and ER stresses are well-known and key features of NASH but were not examined directly in the present study but will certainly be a targeted pathway in future studies utilizing ALT-100 mAb efficacy in NASH. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.